{"id":"NCT02008916","sponsor":"Novartis Pharmaceuticals","briefTitle":"16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients","officialTitle":"A Randomized, Double-blind, Placebo-controlled Phase III Study of Secukinumab to Demonstrate the Efficacy at 16 Weeks and to Assess the Long-term Safety, Tolerability and Efficacy up to 3 Years in Subjects With Active Ankylosing Spondylitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-14","primaryCompletion":"2015-02-23","completion":"2017-12-11","firstPosted":"2013-12-11","resultsPosted":"2018-12-12","lastUpdate":"2019-01-08"},"enrollment":226,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Spondylitis, Ankylosing"],"interventions":[{"type":"DRUG","name":"Secukinumab","otherNames":["AIN457"]},{"type":"DRUG","name":"Placebo secukinumab","otherNames":[]}],"arms":[{"label":"Secukinumab 10 mg/kg i.v. / 300 mg s.c.","type":"EXPERIMENTAL"},{"label":"Secukinumab 10 mg/kg i.v. / 150 mg s.c.","type":"EXPERIMENTAL"},{"label":"Placebo i.v. and s.c.","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to generate 16-week efficacy data, as well as up to 3-year efficacy, safety and tolerability data in subjects with active AS despite current or previous NSAID, DMARD and/or anti-TNF therapy.","primaryOutcome":{"measure":"Number of Participants With 20% Improvement in the Assessment of Spondyloarthritis International Society Criteria Scale / ASAS 20 Response","timeFrame":"16 weeks","effectByArm":[{"arm":"Secukinumab 10 mg/kg i.v. / 150 mg s.c.","deltaMin":43,"sd":null},{"arm":"Secukinumab 10 mg/kg i.v. / 300 mg s.c.","deltaMin":46,"sd":null},{"arm":"Placebo i.v. and s.c.","deltaMin":28,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0093"},{"comp":"OG001 vs OG002","p":"0.0037"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":57,"countries":["United States","Belgium","Czechia","Germany","Greece","Mexico","Portugal","Russia","Spain","United Kingdom"]},"refs":{"pmids":["35305260","34773130","34618347","33722947","32352653","31203228","29273067"],"seeAlso":["http://www.novartisclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":110},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Arthralgia","Respiratory tract infection"]}}